Latest filingOct 02, 2026Most recent Form 4
NGNE
Neurogene Inc.
Insider activity for last month from 09/02 to 10/02. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$01 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly purchases, sales and code-A awards Buys Sells Awards / grants (A)
Code A includes awards, grants and other acquisitions; these are not open-market buys.
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (1)Sep 2026Oct 2026
Top insiders
By absolute net value across the selected period- MR+$19.1k
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period2transactionstxns
- M · Option exercise · dominant2 · 100%
Activity by reported role
A joint filing can contribute to multiple roles2transactionstxns
- Chief executive officer · dominant2 · 100%
Reported Holdings After
Separated by insider, security, and ownership type
McMinn RachelStock Option (Right to Buy) · Direct
0Sep 22, 2026
McMinn RachelCommon Stock · Direct
1,345,063Sep 22, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redSep 02 → Oct 02
LessMore
Filing-only signals
Deterministic matches in the selected period
NGNE transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #234046 | NGNE | McMinn Rachel | CEO | exercise | 756 | $0 | M | 10/02 | 09/22 |
| #234045 | NGNE | McMinn Rachel | CEO | exercise | 756 | $1.91M | M | 10/02 | 09/22 |
Neurogene Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Neurogene Inc.?
McMinn Rachel.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.